China NMPA Drug Inspection - Sichuan Hongpu Pharmaceutical Co., Ltd. - Epimedium
China NMPA drug inspection for Sichuan Hongpu Pharmaceutical Co., Ltd. published December 24, 2021. Drug: Epimedium. On December 24, 2021, the Sichuan Provincial Drug Administration issued Announcement No. 14, identifying 15 batches of p
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Sichuan Hongpu Pharmaceutical Co., Ltd. published December 24, 2021. Drug: Epimedium. On December 24, 2021, the Sichuan Provincial Drug Administration issued Announcement No. 14, identifying 15 batches of p
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox